Business · 23 October 2026
Warp Sciences Raises $215M to Build AI‑Powered Drug Research Labs
Warp Sciences, founded by former OpenAI, Meta, Terremoto Biosciences and Devoted Health leaders, raised $215 million to build chemistry CRO facilities in the US, combining chemists, AI models and robotics. The round was led by Lightspeed with participation from Premji Invest, Mayfield, IVP, Lux, Conviction, Menlo Ventures, 01 Advisors and angel investors including Coinbase CEO Brian Armstrong, Databricks co‑founder Ion Stoica and Figma CEO Dylan Field.
Why it matters
Prioritize integration of AI models into drug discovery workflows; benchmark against Warp's chemist‑robotics pipeline.
For product managers
For your product
What does this mean for your product?
Try it on your product More from this issueAll AI news from 23 Oct →
Get this every morning, written for your product.
Deltaday reads the whole AI news cycle and tells you what changed, whether it's real yet, and what to do about it.